The Investor Database Every Biotech Raise Starts With
900+ verified US biotech VCs with direct partner emails, investment focus, check sizes, and deal stage.
Built for founders. Trusted by fundraising advisors.
Whether you're raising your seed or helping a portfolio company close a Series B, the right VC contacts are already waiting.
Stop building lists. Start closing rounds.
Every entry in BioxList is hand-curated so you know exactly who you're pitching before you write a single word.
Each VC profile includes :
- 📧 Direct partner emails — no gatekeepers, no contact forms
- 🎯 Investment focus — Therapeutics, MedTech, Digital Health, Diagnostics and more
- 💰 Typical check size — from $250K to $10M+
- 📊 Deal stage — Seed, Series A, B and beyond
The data your pitch deck deserves.
Find Your Next Investor With BioxList
A curated database of 900+ US Biotech Venture Capital firms investing across Therapeutics, MedTech, Diagnostics, Biotechnology, Life Sciences IT/AI, Digital Health, and AgriTech.
| Venture Capital | Website | Biotech Sectors | Investment Stages | Location | Contacts |
|---|
Customers are saying
FAQ
What makes your database unique?
- Biotech-only focus: No noise from unrelated industries.
- Deep investor profiles: Funding criteria and even which scientific milestones they prioritize.
Why get a biotech-specific database?
- Save 100+ hours: Replace guesswork with a ready-to-pitch list of investors pre-filtered by your stage, therapy area, and capital needs.
- Avoid mismatches: Know which VCs are actively deploying capital in your niche.
- Boost credibility: Use insider data to craft pitches that resonate with investor priorities.
Who uses BioxList?
- Biotech founders raising Seed to Series C rounds.
- Business development teams at life sciences startups.
- Consultants building investor pipelines for clients.
How to use your database?
Receive an Excel file to manually browse and filter investors by stage, investment focus, or ticket size, then export emails from the CSV file for instant outreach to VC decision-makers. No tech skills required.
Your Precision Fundraising Toolkits :
-
2026 US AgTech VC Database
Regular price €80,00 EURRegular priceUnit price / perSale price €80,00 EUR -
2026 US Biotech VC Database
Regular price €350,00 EURRegular priceUnit price / perSale price €350,00 EUR -
2026 US Biotechnology VC Database
Regular price €220,00 EURRegular priceUnit price / perSale price €220,00 EUR -
2026 US Diagnostics VC Database
Regular price €260,00 EURRegular priceUnit price / perSale price €260,00 EUR -
2026 US Digital Health VC Database
Regular price €340,00 EURRegular priceUnit price / perSale price €340,00 EUR -
2026 US FoodTech VC Database
Regular price €90,00 EURRegular priceUnit price / perSale price €90,00 EUR -
2026 US Life Sciences IT/AI VC Database
Regular price €280,00 EURRegular priceUnit price / perSale price €280,00 EUR -
2026 US MedTech VC Database
Regular price €180,00 EURRegular priceUnit price / perSale price €180,00 EUR
Blog
View all-
Competitor Patent Monitoring in Biotech: Settin...
Stay ahead in the biotech industry. Learn how to monitor competitor patents and set up alerts for new and pending patents for a competitive edge. Uncover the essentials of ethical...
Competitor Patent Monitoring in Biotech: Settin...
Stay ahead in the biotech industry. Learn how to monitor competitor patents and set up alerts for new and pending patents for a competitive edge. Uncover the essentials of ethical...
-
Due Diligence FTO Requirements for Biotech Fund...
Explore the essentials of Due Diligence FTO in biotech fundraising and gain insights on what investors expect to see. A must-read for biotech firms and investors alike.
Due Diligence FTO Requirements for Biotech Fund...
Explore the essentials of Due Diligence FTO in biotech fundraising and gain insights on what investors expect to see. A must-read for biotech firms and investors alike.
-
Public Disclosure Risks in Biotech: Patent Conf...
Explore the intricacies of public disclosure risks in the biotech industry, the importance of patent conflict checks, and strategies to safeguard patents before conferences and publications.
Public Disclosure Risks in Biotech: Patent Conf...
Explore the intricacies of public disclosure risks in the biotech industry, the importance of patent conflict checks, and strategies to safeguard patents before conferences and publications.







